泓博医药:公司经营稳定业务持续向好

Core Viewpoint - The company acknowledges the recent decline in stock price over the past five months, attributing it to multiple factors including macroeconomic environment, industry cycles, and market sentiment [1] Group 1: Stock Performance and Investor Concerns - The company has experienced a continuous stock price decline for five months, which investors are concerned may be linked to shareholder unlocks and reductions [1] - The management emphasizes that stock price fluctuations are market behaviors and not solely reflective of the company's performance [1] Group 2: Company Outlook and Management Response - The company reports stable operations and ongoing positive business development, with management expressing confidence in future growth [1] - The company is committed to focusing on its core business and improving operational quality and profitability to create long-term sustainable value for investors [1] - The management will consider investor suggestions and will disclose any relevant plans in a timely manner [1]